Discoloration, age spots, and brown spots can add years to your appearance. Hydroquinone was the popular treatment for skin discoloration, but it has fallen out of favor due to recent reports and fears that it may be toxic. Women were left with very little options and often turn to medical treatments such as fractional resurfacing or chemical peels. Now there is a new treatment available that has been shown to be more effective than hydroquinone.
Lumixyl,? a non-toxic, non-irritating, synthetic peptide technology has been shown to significantly help improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone. It is now available through select physicians to help their patients achieve the skin they've always wanted. An alternative to all other skin lightening products and systems, this new cosmeceutical skin brightening cream can be found in leading physician offices for $120 per 1 ounce pump. 
Developed by dermatological researchers at Stanford University, Lumixyl's ground-breaking technology is the only peptide shown to measurably promote healthy skin function. Scientific studies indicate it has a mechanism or action that reduces tyrosinase, the enzyme responsible for initiating the overproduction of melanin. It is melanin that can cause uneven pigmentation and dark spots.
Lumixyl is created for patients seeking more even skin-tone including those with:
A clinical study demonstrated that topical use of Lumixyl visibly improves mild to moderate hyperpigmentation with excellent volunteer satisfaction in as little as 8 weeks. Studies show that the key ingredient in Lumixyl, a chain of ten amino acids, promoted the moderation of melanin more efficaciously than hydroquinone. At equal concentrations, skin that was treated with the Lumixyl peptide expressed a reduced production of melanin by as much as 40 percent compared to those treated with hydroquinone, which reduced production by only 7 percent in the study.
"The results of studies conducted at Stanford are impressive, showing a 40 percent improvement in melanin related darkening.," commented Dr. Nowell Solish, Assistant Professor at The University of Toronto, co-director of the Non-Melanoma Skin Cancer clinic at Women's College. "When used as directed, Lumixyl appears to significantly help the skin's ability to diminish dark spots imparting users with brighter, more even skin tone while limiting irritation, red blotches or even sensitivity to sunlight."
Moreover, in-use and Repeated Insult Patch Testing (RIPT) studies confirm that Lumixyl is safe for topical use and does not elicit irritation or allergic reaction. It does not cause increased sensitivity to sunlight as do many commonly used brightening agents and is gentle for all skin types and tones. "Hydroquinone has had some controversy in the recent past and this product offers a non-hydroquinone alternative that shows good clinical efficacy in treating discoloration without causing irritation," stated Dr. Neil Sadick.
Lumixyl Topical Brightening Cr?me can be used alone or if directed by a physician, to compliment other treatments such as Tretinoin, laser resurfacing and SilkPeel?, respectively, to diminish dark spots, uneven pigmentation and improve overall skin tone.
Visible Results without Risk
The RIPT results show that, unlike many alternative lightening ingredients, this peptide does not cause irritation or allergic reactions. Lumixyl is formulated to provide the following key advantages:
Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are co-marketed in the United States by Basis Medical Technologies and Envy Medical.
